phrykt

Maze Therapeutics, Inc. (MAZE): who owns it and who trades it

As of Nov 16, 2026, MAZE insiders reported 100 open-market sales worth $25M and no purchases in the last 12 months, with 91% of the sale value made under pre-set 10b5-1 plans. The largest seller was Harold Bernstein (President), with $9.5M. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Maze Therapeutics

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MAZE

162 funds and institutions reported MAZE shares worth $1.8B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is Frazier Life Sciences Management, L.P. with 9.1%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

Frazier Life Sciences Management, L.P.9.1%
Trv Gp Iv, LLC8.1%
ARCH Venture Management, LLC7.4%
Deep Track Capital, LP6.7%
BlackRock, Inc.6.3%
Jupiter Topco LLC6.2%
T. Rowe Price Investment Management, Inc.4.7%
Logos Global Management LP3.5%
Vanguard Capital Management LLC3.2%
A16z Capital Management, L.L.C.3.1%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Frazier Life Sciences Management, L.P.5.03M9.09%$150M+10%
Trv Gp Iv, LLC4.47M8.08%$134MNo change
ARCH Venture Management, LLC4.12M7.44%$123MNo change
Deep Track Capital, LP3.73M6.74%$111M+7%
BlackRock, Inc.3.50M6.33%$105M+36%
Jupiter Topco LLC3.41M6.16%$102M–
T. Rowe Price Investment Management, Inc.2.60M4.70%$77.7M–
Logos Global Management LP1.94M3.50%$57.7M+57%
Vanguard Capital Management LLC1.78M3.21%$53.1M+24%
A16z Capital Management, L.L.C.1.70M3.08%$50.8MNo change
Venrock Adviser, LLC1.60M2.89%$47.8MNo change
Alphabet Inc.1.39M2.51%$41.4MNo change
Braidwell LP1.14M2.06%$34M–
Farallon Capital Management, L.l.c.1.11M2.00%$33.1M+197%
FMR LLC (Fidelity)1.06M1.91%$31.5M+22%
General Catalyst Group Management, LLC1.04M1.87%$30.9MNo change
State Street Corp997,5331.80%$29.8M+57%
JPMorgan Chase & Co964,0111.74%$28M–
Driehaus Capital Management LLC954,8861.73%$28.5M+50%
Trv Gp V, LLC950,8001.72%$28.4MNo change

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, MAZE insiders reported $0 of open-market purchases and $25M of sales. 91% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$25M
100 trades, 6 people
Sales under a 10b5-1 plan
91%
Share of sale value
Latest trade
Nov 2, 2026
Filed Nov 4, 2026

Purchases and sales by month

$5.4M$5.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 2, 2026Jason V ColomaCEOSale plan2,257$30.12$68KForm 4
Nov 2, 2026Jason V ColomaCEOSale plan336$30.91$10.4KForm 4
Nov 2, 2026Jason V ColomaCEOSale plan26,563$30.09$799KForm 4
Nov 2, 2026Jason V ColomaCEOSale plan5,345$31.05$166KForm 4
Oct 29, 2026Atul DandekarCSBOSale plan7,500$32.07$241KForm 4
Oct 1, 2026Harold BernsteinPresidentSale plan16,141$26.93$435KForm 4
Oct 1, 2026Jason V ColomaCEOSale plan2,593$27.02$70.1KForm 4
Oct 1, 2026Jason V ColomaCEOSale plan31,908$27.02$862KForm 4
Sep 29, 2026Atul DandekarCSBOSale plan7,500$27.06$203KForm 4
Sep 4, 2026Harold BernsteinPresidentSale plan9,705$26.22$254KForm 4
Sep 3, 2026Phillips CourtneyGC and Corp. SecretarySale1,990$26.01$51.8KForm 4
Sep 3, 2026Phillips CourtneyGC and Corp. SecretarySale22$25.78$567Form 4
Sep 3, 2026Atul DandekarCSBOSale3,207$26.01$83.4KForm 4
Sep 3, 2026Atul DandekarCSBOSale36$25.81$929Form 4
Sep 3, 2026Jason V ColomaCEOSale129$25.77$3.3KForm 4
Sep 3, 2026Jason V ColomaCEOSale11,282$26.01$293KForm 4
Sep 3, 2026Harold BernsteinPresidentSale59$25.78$1.5KForm 4
Sep 3, 2026Harold BernsteinPresidentSale5,130$26.01$133KForm 4
Sep 2, 2026Phillips CourtneyGC and Corp. SecretarySale243$27.12$6.6KForm 4
Sep 2, 2026Phillips CourtneyGC and Corp. SecretarySale1,738$26.38$45.8KForm 4
Sep 2, 2026Atul DandekarCSBOSale2,800$26.38$73.9KForm 4
Sep 2, 2026Atul DandekarCSBOSale391$27.12$10.6KForm 4
Sep 2, 2026Jason V ColomaCEOSale1,375$27.12$37.3KForm 4
Sep 2, 2026Jason V ColomaCEOSale9,852$26.38$260KForm 4
Sep 2, 2026Harold BernsteinPresidentSale625$27.12$16.9KForm 4
Sep 2, 2026Harold BernsteinPresidentSale4,481$26.38$118KForm 4
Sep 1, 2026Jason V ColomaCEOSale plan2,593$26.31$68.2KForm 4
Sep 1, 2026Jason V ColomaCEOSale plan31,908$26.29$839KForm 4
Sep 1, 2026Harold BernsteinPresidentSale plan16,141$26.36$425KForm 4
Aug 28, 2026Atul DandekarCSBOSale plan7,500$27.58$207KForm 4
Aug 13, 2026Harold BernsteinPresidentSale plan16,142$27.61$446KForm 4
Aug 3, 2026Jason V ColomaCEOSale plan2,439$26.71$65.1KForm 4
Aug 3, 2026Jason V ColomaCEOSale plan154$27.09$4.2KForm 4
Aug 3, 2026Jason V ColomaCEOSale plan30,304$26.71$809KForm 4
Aug 3, 2026Jason V ColomaCEOSale plan1,604$27.09$43.5KForm 4
Jul 29, 2026Atul DandekarCSBOSale plan400$27.89$11.2KForm 4
Jul 29, 2026Atul DandekarCSBOSale plan7,100$27.31$194KForm 4
Jul 1, 2026Harold BernsteinPresidentSale plan1,200$30.34$36.4KForm 4
Jul 1, 2026Harold BernsteinPresidentSale plan13,409$29.87$401KForm 4
Jul 1, 2026Jason V ColomaCEOSale plan1,597$30.44$48.6KForm 4
Jul 1, 2026Jason V ColomaCEOSale plan2,593$29.98$77.7KForm 4
Jul 1, 2026Jason V ColomaCEOSale plan30,311$29.95$908KForm 4
Jun 29, 2026Atul DandekarCSBOSale plan7,500$28.02$210KForm 4
Jun 23, 2026Jason V ColomaCEOSale plan23,865$26.05$622KForm 4
Jun 22, 2026Jason V ColomaCEOSale plan1,953$26.00$50.8KForm 4
Jun 22, 2026Jason V ColomaCEOSale plan2,040$26.00$53KForm 4
Jun 1, 2026Jason V ColomaCEOSale plan6,090$26.20$160KForm 4
Jun 1, 2026Jason V ColomaCEOSale plan553$26.24$14.5KForm 4
Jun 1, 2026Harold BernsteinPresidentSale plan1,600$26.36$42.2KForm 4
Jun 1, 2026Harold BernsteinPresidentSale plan13,253$25.57$339KForm 4
May 29, 2026Atul DandekarCSBOSale plan7,500$26.34$198KForm 4
May 26, 2026Jason V ColomaCEOSale plan25,582$26.02$666KForm 4
May 22, 2026Jason V ColomaCEOSale plan4,504$26.00$117KForm 4
May 22, 2026Jason V ColomaCEOSale plan2,478$26.00$64.4KForm 4
May 15, 2026Jason V ColomaCEOSale plan116$26.00$3KForm 4
May 15, 2026Jason V ColomaCEOSale plan1,822$26.00$47.4KForm 4
May 14, 2026Harold BernsteinPresidentSale plan15,000$26.22$393KForm 4
Apr 29, 2026Atul DandekarCSBOSale plan7,500$25.37$190KForm 4
Apr 1, 2026Harold BernsteinPresidentSale plan11,352$29.24$332KForm 4
Apr 1, 2026Harold BernsteinPresidentSale plan3,348$30.06$101KForm 4
Apr 1, 2026Harold BernsteinPresidentSale plan300$31.07$9.3KForm 4
Apr 1, 2026Amy BachrodtVice presidentSale plan300$30.34$9.1KForm 4
Apr 1, 2026Amy BachrodtVice presidentSale plan2,200$29.32$64.5KForm 4
Mar 30, 2026Atul DandekarCSBOSale plan6,710$29.26$196KForm 4
Mar 30, 2026Atul DandekarCSBOSale plan790$30.02$23.7KForm 4
Mar 20, 2026Harold BernsteinPresidentSale plan6,161$48.20$297KForm 4
Mar 20, 2026Harold BernsteinPresidentSale plan3,795$49.32$187KForm 4
Mar 20, 2026Harold BernsteinPresidentSale plan5,044$50.02$252KForm 4
Mar 10, 2026Harold BernsteinPresidentSale plan348$51.02$17.8KForm 4
Mar 10, 2026Harold BernsteinPresidentSale plan29,652$50.45$1.5MForm 4
Mar 2, 2026Amy BachrodtVice presidentSale plan1,300$44.44$57.8KForm 4
Mar 2, 2026Amy BachrodtVice presidentSale plan3,700$45.47$168KForm 4
Feb 27, 2026Atul DandekarCSBOSale plan3,761$45.72$172KForm 4
Feb 27, 2026Atul DandekarCSBOSale plan3,739$45.13$169KForm 4
Feb 2, 2026Harold BernsteinPresidentSale plan600$44.21$26.5KForm 4
Feb 2, 2026Harold BernsteinPresidentSale plan8,364$45.89$384KForm 4
Feb 2, 2026Harold BernsteinPresidentSale plan100$47.23$4.7KForm 4
Feb 2, 2026Harold BernsteinPresidentSale plan5,936$46.37$275KForm 4
Feb 2, 2026Amy BachrodtVice presidentSale plan736$46.63$34.3KForm 4
Feb 2, 2026Amy BachrodtVice presidentSale plan4,064$46.03$187KForm 4
Feb 2, 2026Amy BachrodtVice presidentSale plan200$44.15$8.8KForm 4
Jan 29, 2026Atul DandekarCSBOSale plan1,200$43.18$51.8KForm 4
Jan 29, 2026Atul DandekarCSBOSale plan2,800$45.01$126KForm 4
Jan 29, 2026Atul DandekarCSBOSale plan3,500$44.04$154KForm 4
Jan 22, 2026Amy BachrodtVice presidentSale plan5,000$45.52$228KForm 4
Jan 7, 2026Harold BernsteinPresidentSale plan25,156$40.20$1MForm 4
Jan 7, 2026Catherine A. SohnDirectorSale26,920$39.11$1.1MForm 4
Jan 6, 2026Catherine A. SohnDirectorSale2,493$38.62$96.3KForm 4
Jan 5, 2026Harold BernsteinPresidentSale plan412$40.00$16.5KForm 4
Jan 2, 2026Harold BernsteinPresidentSale plan4,432$40.43$179KForm 4
Jan 2, 2026Amy BachrodtVice presidentSale plan2,405$38.70$93.1KForm 4
Jan 2, 2026Amy BachrodtVice presidentSale plan2,595$39.57$103KForm 4
Dec 30, 2025Atul DandekarCSBOSale plan100$40.36$4KForm 4
Dec 30, 2025Amy BachrodtVice presidentSale plan5,000$40.08$200KForm 4
Dec 29, 2025Atul DandekarCSBOSale plan6,035$41.13$248KForm 4
Dec 29, 2025Atul DandekarCSBOSale plan66,365$40.51$2.7MForm 4
Dec 29, 2025Harold BernsteinPresidentSale plan17,200$40.93$704KForm 4
Dec 29, 2025Harold BernsteinPresidentSale plan27,800$40.34$1.1MForm 4
Dec 29, 2025Amy BachrodtVice presidentSale plan600$41.16$24.7KForm 4
Dec 29, 2025Amy BachrodtVice presidentSale plan9,400$40.54$381KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Harold BernsteinPresident, R&D & CMO–$9.5MOct 1, 2026
Jason V ColomaChief Executive Officer, Director–$7.2MNov 2, 2026
Atul DandekarCSBO–$5.5MOct 29, 2026
Amy BachrodtSVP, Finance–$1.6MApr 1, 2026
Catherine A. SohnDirector–$1.1MJan 7, 2026
Phillips CourtneyGC and Corp. Secretary–$105KSep 3, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MAZE short interest

High short interest. 12.0% of MAZE shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 69%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 6.68M MAZE shares were sold short, 12.0% of the shares outstanding, down 11.2% from the report before. At the average daily volume of 763,468 shares, buying them all back would take about 8.8 trading days (days to cover).

Shares short, % of all shares

12.0%May 15Oct 3014.5%

Days to cover

8.8May 15Oct 3017.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20266.68M12.03%-11%763,4688.8
Oct 15, 20267.53M13.55%+15%745,71210.1
Sep 30, 20266.57M11.82%+16%1.08M6.1
Sep 15, 20265.68M10.22%-4%546,17910.4
Aug 31, 20265.92M10.65%-1%368,76416.1
Aug 14, 20265.99M10.78%+5%370,29516.2
Jul 31, 20265.68M10.26%+3%357,59815.9
Jul 15, 20265.53M9.98%No change651,9478.5
Jun 30, 20265.53M9.99%+36%1.03M5.4
Jun 15, 20264.06M7.33%+4%527,4407.7
May 29, 20263.90M7.04%-1%442,1258.8
May 15, 20263.95M7.14%-9%533,2497.4

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Maze Therapeutics company events

Maze Therapeutics filed 10 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 9, 2026.

  1. Nov 9, 2026ResultsReleased financial results. Filing
  2. Oct 16, 2026AgreementThe information contained below under Item 3.02 is hereby incorporated by reference in response to this Item 1.01 of Form 8-K. Item 3.02. Filing
  3. Aug 17, 2026LeadershipThe Board of Directors of Maze Therapeutics, Inc. appointed Paula A. Johnson, M.D., M.P.H. as a Class III director and Sophie Kornowski, Pharm.D. as a Class I director, in each case effective August 13, 2026. Filing
  4. Aug 11, 2026ResultsReleased financial results. Filing
  5. Jun 10, 2026VoteReported shareholder vote results. Filing
  6. May 22, 2026LeadershipAmy Bachrodt gave notice that she will resign as Senior Vice President, Finance of Maze Therapeutics, Inc., effective June 1, 2026. Filing
  7. May 12, 2026ResultsReleased financial results. Filing
  8. Apr 22, 2026AnnouncementMaze Therapeutics, Inc., a Delaware corporation, entered into an underwriting agreement with Leerink Partners LLC as sole underwriter, pursuant to which the Company agreed to issue and sell an aggregate of (a) 5,540,000 shares of its common stock and (b) pre-funded warrants to purchase 850,000… Filing
  9. Mar 25, 2026LeadershipThe Board of Directors of the Company appointed Neil Kumar as a Class I director, effective March 27, 2026. Filing
  10. Feb 4, 2026AgreementMaze Therapeutics, Inc. entered into that certain Loan and Security Agreement, by and among the Company, as borrower, the lenders from time to time party thereto, and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent for itself and the lenders party thereto, which… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Maze Therapeutics financials

Famous investors that hold MAZE

1 of the 50 well-known investors we track reported holding MAZE in their latest 13F filing. The largest position is Ken Griffin's, worth $42.9M.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20261.58M$42.9M0.0%+85%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named MAZE in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Third Rock Ventures IV, L.P.13G/A6.7%
Nov 16, 2026Third Rock Ventures IV, L.P.13G/A6.7%

Questions about Maze Therapeutics, Inc. (MAZE) stock

Who owns the most MAZE stock?

The largest reported owner of Maze Therapeutics, Inc. (MAZE) is Frazier Life Sciences Management, L.P., with 9.1% of the company. In total, 162 funds and institutions reported holding MAZE at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are MAZE insiders buying or selling?

In the last 12 months, MAZE insiders reported no open-market purchases and 100 sales worth $25M. The latest trade was on Nov 2, 2026. See every trade.

What is the short interest in MAZE?

As of Oct 30, 2026, 6.68M MAZE shares were sold short, 12.0% of the shares outstanding, down 11.2% from the report before. At the average daily volume of 763,468 shares, buying them all back would take about 8.8 trading days (days to cover). See the history.

Which famous investors hold MAZE?

1 of the 50 well-known investors we track reported MAZE in their latest 13F filing, including Ken Griffin. The largest position is worth $42.9M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.